Omnicef
Utilized to relieve secondary bacterial infections to alleviate fever and inflammation.
- Category
- Antibiotics
- Active ingredient
- Cefdinir
- Supply
- Pharmacy
- Route
- Oral use
- Form
- Tablet
- Strengths
- 300mg
Omnicef details
- Conditions
- Community-acquired Pneumonia · Acute Bacterial Otitis Media · Pharyngitis · Acute Exacerbation of Chronic Bronchitis
- Therapeutic class
- Cephalosporin antibiotic
- Pharmacological class
- Cephalosporin
- Contraindications
- hypersensitivity to cephalosporins
- Precautions and warnings
- complete the full course of treatment; may cause stools to appear red
- Minor side effects
- diarrhoea; nausea; headache
- Moderate side effects
- rash; abdominal pain
- Dosage forms
- Tablet
- Administration route
- Oral use
- Supply category
- Pharmacist only, dispensed without a prescription
- Manufacturer
- AbbVie
- Onset Time
- 1–2 hours
- Duration
- 12–24 hours
- Storage instructions
- Store at controlled room temperature.
- Drug interactions
- antacids; iron supplements
- Age restrictions
- Weight-based dosing applies for paediatric use.
Serious side effects
pseudomembranous colitis, requires immediate medical attention; anaphylaxis, requires immediate medical attention
Patient summary
Utilized to relieve secondary bacterial infections to alleviate fever and inflammation.
Mechanism of action
This medicine acts by inhibiting cell wall synthesis, causing bacterial death by binding to essential penicillin-binding proteins in susceptible microorganisms.
Pregnancy and breastfeeding
Pregnancy: Considered safe but consult physician. Breastfeeding: Consult physician.
Where this medicine is registered
- Singapore
- Hong Kong
- Thailand
- Malaysia
- Philippines
- Indonesia
- Taiwan
- South Korea
- Japan
- Australia
- New Zealand
- UAE
- South Africa
About Omnicef
Omnicef is a brand of Cefdinir, an antibiotic used to address Community-acquired Pneumonia, Acute Bacterial Otitis Media and Pharyngitis. Manufactured by AbbVie, the medication comes in 300mg tablets. Clinical use of this cephalosporin involves stopping the growth of bacteria to assist in managing these specific bacterial infections.
Omnicef availability in Asia
Omnicef is registered across 13 markets including the Philippines, Indonesia and Taiwan, with availability also in South Korea, Japan and the UAE. Generic Cefdinir, much of which is manufactured in India, often provides a more affordable alternative to the original brand for expats living in regions far from their home medical systems. As with all antibiotics, this medication is best used under a doctor’s care to ensure appropriate treatment of the infection.